Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Ruxolitinib can help regrow hair in severe alopecia areata.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

ROOT HAIR SPECIFIC 10 (RHS10) reduces the length of root hairs in Arabidopsis plants.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

AMPK activation may reduce melanoma risk in red-haired individuals.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.